Suspension of trading

Valuation CureVac

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-01-05 EST			5-day change	1st Jan Change
4.660 ^USD	-0.21%		-.--%	+3.10%

04-15	Evotec Taps CureVac Executive as COO	MT
01-06	CureVac ends coverage after BioNTech acquisition

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2026
Market Cap ¹	14,306	6,418	1,147	942.7	764.9	1,049
Change	-	-55.14%	-82.12%	-17.82%	-18.86%	-
Enterprise Value (EV)	13,036	5,635	680.3	582.1	322.1	1,049
Change	-	-56.77%	-87.93%	-14.43%	-44.66%	-
P/E	-82.7x	-15.5x	-4.57x	-3.57x	4.74x	-
PBR	15.1x	9.33x	2.2x	1.82x	1.1x	-
PEG	-	-0x	0.1x	0.3x	-0x	-
Capitalization / Revenue	292,548,307x	62,313,540x	17,015,281x	17,522,654x	1,429,206x	-
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.98	-2.21	-1.32	-1.18	0.72	-
Distribution rate	-	-	-	-	-	-
Net sales	48.9	103	67.42	53.8	535.2	-
EBITDA	-99.14	-762.4	-225.7	-250.8	196.5	-
EBIT	-109.8	-778.1	-249.5	-274.2	177.7	-
Net income ¹	-129.1	-411.7	-249	-260.2	162.2	-132.4
Net Debt	-1,270	-782.6	-466.9	-360.6	-442.8	-
Reference price ²	81.070	34.310	6.030	4.210	3.410	4.660
Nbr of stocks (in thousands)	176,460	187,050	190,244	223,924	224,314	225,182
Announcement Date	4/15/21	4/28/22	4/25/23	4/24/24	4/10/25	-